CHROME 2.0 Reduces Psychotropic Prescribing, Improving Neuropsychiatric Symptoms and Falls in People With Dementia.

A significant decrease in psychotropic medication can be achieved concurrently with a marked improvement in both neuropsychiatric symptoms and falls. Psychotropic overprescription seems related to a culture of overestimating the capabilities of psychotropics while underestimating the potential of psychosocial interventions and the need for human contact of PwD. CHROME's limitation of psychotropics for severe cases contributed to shifting from a drug-centered care paradigm to a psychosocially more humane and integrative one that seems cost-effective and replicable, and should be further researched and implemented.